The AHA Sept. 9 urged the Centers for Medicare & Medicaid Services to work with Congress on providing a pay increase for physicians in 2025 and develop a long-term plan for sustainable physician payment. AHA expressed its concerns to CMS while commenting on the agency's calendar year 2025 physician fee schedule proposed rule, in which the proposed payment update would reduce payments approximately 2.8% from CY 2024 levels. Additionally, the AHA shared concerns on CMS' proposed updates to Medicare Parts A and B overpayment policies, saying the agency’s proposed 180-day window to suspend reporting and repayment to complete overpayment investigations is insufficient. The AHA proposed that CMS provide "sufficient exceptions" when complex, multi-year or multi-site investigations require time beyond 180 days. The AHA was pleased to see proposed extensions of several telehealth waivers, including virtual supervision waivers, as well as proposed policies to exclude anomalous spending from Medicare Shared Savings Program financial calculations.
 

Related News Articles

Headline
Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced, along with providing…
Headline
Health care executives will share trauma-informed strategies to reduce violence, support staff and foster healing during an AHA webinar Dec…
Perspective
Public
Nov. 20 is National Rural Health Day. It’s an opportunity to recognize the many ways rural hospitals advance health in their communities, as well as raise…
Headline
The AHA will host the third session of its virtual webinar series on workforce development Nov. 19 at 12:30 p.m. ET. This session will explore how centralized…
Headline
A blog by Michelle Schweitzer, executive director of advanced practice providers at WakeMed Health and Hospitals, and Dawn Mutchko, principal consultant at…
Chairperson's File
Public
In last month’s Chair File, we talked about some of the key priorities the AHA has for the remainder of 2025, one of which is protecting the 340B Drug Pricing…